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Male to female ratio was 17:29, mean age was 52.7 years (ranged from 
31 to 74 years). Relapse free time varied from 6 months to 5 years. All 
patients had abnormal radiographic ﬁnding. Radiography was done on 
routine control examination in 60% of patients, who had no symptoms. 
The most common primary malignancy was laryngeal carcinoma 
(22pts-47.8%), breast carcinoma (6pts-13%), adenocarcinoma of the 
colon (5pts-10.8%), thyroid gland carcinoma (5pts-10.8%) cervical 
carcinoma of the uterus (3pts-6.52%) and other, less common tumors 
(stomach, esophagus, prostate, tongue). Bronchoscopic ﬁnding revealed 
that endoluminal metastases were more common in right lung (in 31 
pts-67.4%). Most of the metastases were seen in upper lobe bronchi 
(52%). Biopsy was performed and pathohistological veriﬁcation was 
obtained in all patients. In more then 1/2 of the patients histologic type 
was squamocellular carcinoma.
We can conclude that ﬁberoptic bronchoscopy with biopsy is simple, 
cheap technique in diagnosis of endobronchial metastases. Histological 
veriﬁcation is 100% in centrally localized lesions.
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I would like to present the mediastinal adenosuamous cell carcinoma 
involved the left subclavian artery, left brachiocepharic vein, left recur-
rent nerve and left phrenic nerve. 
A 48-year-old male visited our institute with abnormal ﬁndings of 
left upper mediastinal on chest X ray. The left subclavian artery was 
involved with the tumor of 5.0 X 4.5 cm in diameter on chest CT scan. 
However, there were no left shoulder pain and lower arterial pressure 
of the left upper extremities than the right upper extremities. VATS 
(video-assisted thoracoscopic surgery) was performed for pathologi-
cal diagnosis, and the pathological diagnosis was adenosquamous cell 
carcinoma. PET (positron emission tomography) scan revealed the 
just uptake of the tumor site. So, we performed the mediastinal tumor 
resection and the combined resection of the left subclavian artery, the 
left brachiocepharic vein, left recurrent nerve and left phrenic nerve. 
The left subclavian artery reconstructed with Gelwaeve 8mm, and the 
left brachiocepharic vein reconstructed with ringed e-PTFE 10mm. The 
postoperative course was smooth and not eventful, he was discharge on 
the 10 days after operation.
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The aim of the study was to analyse clinical features and 1-yr survival 
rate of bronchial carcinoid patients diagnosed at the Institute of Lung 
Diseases and TB in Belgrade 1996-2006. 
The group consists of 58 pts (30 females and 28 males), the average 
age of 48 ys (17 - 75). 57 of them underwent operation: lobectomy in 
34pts (58.6.%), pneumonectomy in 11pts(19%), atypical resection in 
9pts (15.5%), bilobectomy in 3pts (5.2%). Hystologic ﬁnding of typical 
carcinoid tumor was in 39pts (67.2%), while atypical in 19pts (32.8%). 
Central tumor type was noted in 30pts(51.7%) and peripheral in 28pts 
(48.3%). CT scan showed that majority of peripheral tumors were 
3-3.5cmX4-4.5cm in diameter, with the exception of 1 case with the 
tumor size 8x7cm and 2 of size 6x5cm.
The most frequent symptoms were cough -30pts (51.7%), chest pain-
25pts (43.1%), dyspnoea -20pts (34.5%), haemoptysis-19pts (32.7%), 
fever-18pts(31.0%), weight loss-13pts (22.4%) and fatigue-12pts 
(20.7%). Majority of pts had disease symptoms lasting either 1 year 
and longer-25pts (43.1%) or less than 3 months -16pts (27.6%).
Five pts (8.6%) had associated neuroendocrine disorder or tumor either 
in the previous history or at the same time of bronchial carcinoid tumor 
diagnosis. Only one pt with Kushing Sy persisting after operation of 
gonadotropic adenoma of pituitary gland, has shown to have hormonal 
activity of the peripheral bronchial carcinoid tumor since this Sy re-
solved after lung operation.
The 1-year follow-up analysis shows 1-year survival rate of 86.2% 
(50pts): 8pts died within the ﬁrst year after diagnosis or operation. One 
pt died 6th day after operation due to fatal pulmonary embolism, and 
other 7 pts died due to metastatic disease relapse 
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Background: Insulin-like Growth Factor-1 (IGF-1) and its receptor 
(IGF-1R) are important for transformation and growth of malignant 
cells and for the prevention of apoptosis. IGF-1R is often over-ex-
pressed in malignant tumors and several oncogenes depend on intact 
IGF-1R to achieve their transforming activity. 
Recently, members of the cyclolignan family were identiﬁed as poten-
tial inhibitors of the IGF-1 receptor tyrosine kinase. Picropodophyllin 
(PPP), in particular, shows promise since it demonstrates selectivity for 
IGF-1R without inhibiting activity of the insulin receptor or other more 
distantly related receptors. There is, however, on ongoing debate if 
inhibition of microtubule assembly contributes to the cytotoxic effects 
of PPP as this is the major mechanism of action for its epimer podo-
phyllotoxin, PPT. Tumor cells of lung cancer also express IGF-1-re-
ceptors, but their role in the malignant phenotype is still not clear. The 
aim of this study was to investigate the role of IGF-1R in lung cancer 
and to evaluate its potential as a therapeutic target through use of PPP, 
a speciﬁc tyrosine kinase inhibitor of IGF-1R. We also investigated 
the relation between IGF-1 receptor status in cells and sensitivity to 
conventional and experimental chemotherapeutic agents, including PPT 
and other microtubule inhibiting agents.
